C.R. Bard Pays $48 Million To Settle Brachytherapy False Claims Act Allegations
This article was originally published in The Gray Sheet
Executive Summary
The settlement addresses allegations by the Justice Department that the company provided kickbacks to Medicare customers and physicians from 1998 to 2006 to purchase brachytherapy seeds used to treat prostate cancer.